Replies to post #1930 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ABBV 1Q21 Mavyret sales=$415M, -14% QoQ:

https://news.abbvie.com/news/press-releases/abbvie-reports-first-quarter-2021-financial-results.htm

The $415M consisted of: $170M US (-23% QoQ); and $245M ex-US (-6%, QoQ).

ABBV’s prior guidance for full-year 2021 Mavyret sales is $2.0B (#msg-161451655). This figure could still be met if patient starts (especially in the US) pick up due to lessening of COVID; however, ABBV may lower the guidance during today’s CC.